HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Circumvention of P-gp and MRP2 mediated efflux of lopinavir by a histidine based dipeptide prodrug.

AbstractPURPOSE:
This study was aimed to develop a novel Histidine-Leucine-Lopinavir (His-Leu-LPV) dipeptide prodrug and evaluate its potential for circumvention of P-gp and MRP2-mediated efflux of lopinavir (LPV) indicated for HIV-1 infection.
METHODS:
His-Leu-LPV was synthesized following esterification of hydroxyl group of LPV and was identified by (1)H NMR and LCMS/MS techniques. Aqueous solubility, stability and cell cytotoxicity of prodrug was determined. Uptake and permeability studies were carried out using P-gp (MDCK-MDR1) and MRP2 (MDCK-MRP2) transfected cell lines. To further delineate prodrug uptake, prodrug interaction with influx transporters (PepT1 and PHT1) was determined. Enzymatic hydrolysis and reconversion of His-Leu-LPV to LPV was examined using Caco-2 cell homogenates.
RESULTS:
Aqueous solubility generated by the prodrug was markedly higher relative to unmodified LPV. Importantly, His-Leu-LPV displayed significantly lower affinity towards P-gp and MRP2 as evident from higher uptake and transport rates. [3H]-GlySar and [3H]-l-His uptake receded to approximately 30% in the presence of His-Leu-LPV supporting the PepT1/PHT1 mediated uptake process. A steady regeneration of LPV and Leu-LPV in Caco-2 cell homogenates indicated His-Leu-LPV undergoes both esterase and peptidase-mediated hydrolysis.
CONCLUSION:
Histidine based dipeptide prodrug approach can be an alternative strategy to improve LPV absorption across poorly permeable intestinal barrier.
AuthorsAbhirup Mandal, Dhananjay Pal, Ashim K Mitra
JournalInternational journal of pharmaceutics (Int J Pharm) Vol. 512 Issue 1 Pg. 49-60 (Oct 15 2016) ISSN: 1873-3476 [Electronic] Netherlands
PMID27543355 (Publication Type: Journal Article)
CopyrightCopyright © 2016 Elsevier B.V. All rights reserved.
Chemical References
  • ABCC2 protein, human
  • ATP Binding Cassette Transporter, Subfamily B, Member 1
  • Carrier Proteins
  • Dipeptides
  • Membrane Transport Proteins
  • Multidrug Resistance-Associated Protein 2
  • Multidrug Resistance-Associated Proteins
  • Nerve Tissue Proteins
  • Peptide Transporter 1
  • Prodrugs
  • SLC15A4 protein, human
  • Symporters
  • Lopinavir
  • histidylleucine
Topics
  • ATP Binding Cassette Transporter, Subfamily B, Member 1 (metabolism)
  • Carrier Proteins (metabolism)
  • Cell Survival (drug effects)
  • Cells, Cultured
  • Dipeptides (chemistry, pharmacokinetics)
  • Drug Stability
  • Humans
  • Lopinavir (chemistry, pharmacokinetics, pharmacology)
  • Membrane Transport Proteins
  • Multidrug Resistance-Associated Protein 2
  • Multidrug Resistance-Associated Proteins (metabolism)
  • Nerve Tissue Proteins (metabolism)
  • Peptide Transporter 1
  • Prodrugs (chemical synthesis, chemistry, pharmacokinetics, pharmacology)
  • Solubility
  • Symporters (metabolism)
  • Transfection

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: